SPONSOR
Melanoma Institute Australia
Total Trials
3
Recruiting
3
Phases
Phase 2
Conditions studied: Cutaneous MelanomaMucosal MelanomaMelanoma MetastaticMelanomaCutaneous Squamous Cell CarcinomaBasal Cell CarcinomaMerkel Cell CarcinomaSolid Tumor
Melanoma Institute Australia is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Cutaneous Melanoma, Mucosal Melanoma, Melanoma Metastatic, Melanoma.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Melanoma Institute Australia
How many clinical trials has Melanoma Institute Australia sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Melanoma Institute Australia, of which 3 are actively recruiting participants. These trials cover conditions including Cutaneous Melanoma, Mucosal Melanoma, Melanoma Metastatic. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Melanoma Institute Australia research focus on?
Melanoma Institute Australia clinical trials span Cutaneous Melanoma, Mucosal Melanoma, Melanoma Metastatic, Melanoma, Cutaneous Squamous Cell Carcinoma, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Melanoma Institute Australia clinical trial?
To participate in a Melanoma Institute Australia trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Melanoma Institute Australia trials with current recruitment status updated daily.
Clinical Trials by Melanoma Institute Australia
NCT06999980 Phase 2
Recruiting
Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation)
Cutaneous Melanoma
NCT06767306 Phase 2
Recruiting
Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma
Melanoma Metastatic
NCT06536257
Recruiting
Personalised Immunotherapy Platform
Melanoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology